US Broker Ratings

Premier, Inc. (PINC) Stock Analysis: Exploring the 2.97% Dividend Yield Amidst Market Challenges

Investors eyeing the healthcare sector might want to take a closer look at Premier, Inc. (NASDAQ: PINC), a notable player in the health information services industry. With its headquarters in..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Exploring the 20.82% Potential Upside

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a stalwart in the healthcare sector with a focus on medical instruments and supplies, is currently drawing investor attention with a notable potential upside of..

Haemonetics Corporation (HAE) Stock Analysis: A Look at the 6.16% Potential Upside Amid Robust Analyst Support

Haemonetics Corporation (NYSE: HAE), a notable player in the healthcare sector, continues to attract investor interest with its innovative suite of medical technologies and a promising 6.16% potential upside based..

Supernus Pharmaceuticals, Inc. (SUPN): Investor Outlook Reveals 34% Potential Upside

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is emerging as a notable player in the healthcare sector, particularly within the specialized drug manufacturing industry. Based in Rockville, Maryland, this biopharmaceutical company focuses..

ImmunityBio, Inc. (IBRX) Stock Analysis: Unveiling a 374% Potential Upside with Strong Buy Ratings

ImmunityBio, Inc. (NASDAQ: IBRX) has emerged as a compelling player in the biotechnology sector, captivating investor attention with its robust potential upside of 374.42%. Headquartered in San Diego, California, ImmunityBio..

Certara, Inc. (CERT) Stock Analysis: Potential 49% Upside Beckons Healthcare Investors

Certara, Inc. (NASDAQ: CERT), a leader in the healthcare sector’s health information services industry, offers investors a compelling narrative as it navigates through the complexities of drug discovery and development...

Concentra Group Holdings Parent (CON) Stock Analysis: Uncovering a 38.54% Potential Upside

Concentra Group Holdings Parent, Inc. (CON) emerges as an intriguing prospect for investors eyeing the healthcare sector, particularly within the medical care facilities industry. Based in Addison, Texas, Concentra specializes..

Immunovant, Inc. (IMVT) Stock Analysis: A Biotech Gem with a 66% Upside Potential

Immunovant, Inc. (IMVT), a clinical-stage biotech firm, has recently captured the attention of investors seeking growth opportunities in the healthcare sector. With its focus on developing monoclonal antibodies for autoimmune..

Disc Medicine, Inc. (IRON) Stock Analysis: A Biotech Gem with a 23% Potential Upside

Disc Medicine, Inc. (NASDAQ: IRON) has caught the attention of individual investors, thanks to its robust performance metrics and promising future in the biotech sector. Headquartered in Watertown, Massachusetts, Disc..

Merus N.V. (MRUS) Stock Analysis: Biotechnology Innovator with a 1.09% Upside Potential

Merus N.V. (MRUS), a trailblazing name in the biotechnology sector, is currently making waves in the healthcare industry with its innovative approaches to antibody therapeutics. Headquartered in the Netherlands, this..

Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook Shows Promising 21.88% Upside in Biotechnology Sector

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a rising star in the biotechnology sector, has captured the attention of investors with a market cap of $3.71 billion. The company is making significant..

Amneal Pharmaceuticals (AMRX): Analyst Ratings Signal Potential Upside for Investors

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) stands as a significant player in the healthcare sector, specifically within the drug manufacturing industry focused on specialty and generic pharmaceuticals. With a market capitalization..

LeMaitre Vascular, Inc. (LMAT) Investor Outlook: Navigating a 23.79% Potential Upside in the Healthcare Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a prominent player in the medical instruments and supplies industry, continues to draw attention from investors looking to capitalize on its robust growth trajectory and..

Warby Parker Inc. (WRBY) Stock Analysis: 18% Potential Upside in Sight for the Eyewear Innovator

Warby Parker Inc. (NYSE: WRBY), a prominent player in the healthcare sector, specifically within the medical instruments & supplies industry, has been catching the eyes of investors with its innovative..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 48.44% Potential Upside in the Growing Medical Devices Sector

UFP Technologies, Inc. (NASDAQ: UFPT), a key player in the healthcare sector specializing in medical devices, offers a compelling investment opportunity with a projected potential upside of 48.44%. This potential..

Amicus Therapeutics, Inc. (FOLD) Stock Report: Exploring a Promising 60% Upside Potential

Amicus Therapeutics, Inc. (NASDAQ: FOLD), a prominent player in the biotechnology sector focused on rare diseases, is gaining significant attention from investors. With a market capitalization of $3.05 billion, this..

Apellis Pharmaceuticals (APLS) Stock Analysis: Exploring a 75.8% Potential Upside in Biotech Innovation

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), a biopharmaceutical company at the frontier of addressing diseases with high unmet needs, has recently emerged as a compelling focus for investors. With a current..

Belite Bio, Inc (BLTE) Stock Analysis: Navigating a $4.75 Billion Market Cap in the Biotech Sector

Belite Bio, Inc (BLTE), a clinical-stage biopharmaceutical company, is attracting significant investor interest as it navigates the intricate landscape of biotechnology. With a robust market capitalization of $4.75 billion, Belite..

Veracyte, Inc. (VCYT) Stock Analysis: Riding the Wave of Revenue Growth in the Diagnostics Sector

Veracyte, Inc. (NASDAQ: VCYT), a prominent player in the healthcare sector specializing in diagnostics and research, is capturing the attention of investors with its solid revenue growth and expanding portfolio..

Kymera Therapeutics, Inc. (KYMR)

⚠️ No article content returned.

..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds